Centrum 7/6  banner

Andrea Harrison leaves CVS

Andrea Harrison leaves CVS

WOONSOCKET, R.I. — CVS vice president of merchandising for beauty and personal care Andrea Harrison has left the company for “a new opportunity,” she wrote on LinkedIn. After 19 years with CVS, “it was a bittersweet departure with so many memories and so hard leaving an amazing team,” she wrote. “There are more people to

Bayer and Dr. Reddy’s ink deal to market, distribute second brand of vericiguat in India

Bayer and Dr. Reddy’s ink deal to market, distribute second brand of vericiguat in India

HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. and Bayer have partnered to market and distribute a second brand of vericiguat in India. Under the terms of their agreement, Bayer has granted nonexclusive rights to Dr. Reddy’s under the brand name Gantra. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, in India, is indicated, along with guideline-based

WBA beats estimates for Q2 sales and profits

WBA beats estimates for Q2 sales and profits

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. topped analysts’ forecasts for second quarter revenue and adjusted earnings. WBA posted adjusted earnings per share of $1.20, well above Wall Street’s predicted 82 cents. Sales of $37.05 billion exceeded the estimated $36.22 billion. The company posted a net loss of $5.91 billion, or $6.85 per share, for

Dr. Reddy’s inks exclusive distribution deal for Sanofi vaccines in India

Dr. Reddy’s inks exclusive distribution deal for Sanofi vaccines in India

HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. has entered into an exclusive partnership with Sanofi Healthcare India Private Ltd. to promote and distribute the latter’s vaccine brands across private markets in India. Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute Sanofi’s well established and trusted paediatric and adult vaccine brands

Dr. Reddy’s launches Versavo (bevacizumab) in the UK

Dr. Reddy’s launches Versavo (bevacizumab) in the UK

HYDERABAD, India — Dr. Reddy’s Laboratories, a global pharmaceutical company, has introduced Versavo (bevacizumab) in the United Kingdom. Dr. Reddy’s Versavo is a biosimilar of Avastin and indicated for the treatment of several types of cancers, including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer,

Circana names 2023 CPG Growth Leaders

Circana names 2023 CPG Growth Leaders

CHICAGO – Circana, a leading advisor on the complexity of consumer behavior, on Monday issued its annual Growth Leaders rankings. The firm analyzed the growth performance of hundreds of public and private consumer packaged goods (CPG) companies ranging from $100 million to $60 billion in annual sales to develop the rankings. Circana will highlight the

Camber launches generic Gralise

Camber launches generic Gralise

PiISCATAWAY, N.J. — Camber Pharmaceuticals has added gabapentin tablets (generic for Gralise) to its portfolio. Camber already offers gabapentin tablets and capsules (generic for Neurontin). Generics for Gralise and Neurontin are not interchangeable. Gabapentin tablets (generic for Gralise) are indicated for the management of postherpetic neuralgia (PHN). Gabapentin tablets (generic for Gralise) 300 mg and

AllianceRx Walgreens chosen as exclusive distributor of Vivjoa

AllianceRx Walgreens chosen as exclusive distributor of Vivjoa

DEERFIELD, Ill. — Specialty pharmacy patients now have exclusive access to VIVJOA through AllianceRx Walgreens Pharmacy. VIVJOA (oteseconazole), manufactured by Mycovia Pharmaceuticals, Inc., is the first FDA-approved medication to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in post-menopausal women or women who are not of reproductive potential. The addition of this medication brings Walgreens enterprise specialty’s number of exclusive

CRN challenges constitutionality of New York law

CRN challenges constitutionality of New York law

WASHINGTON — The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today announced the filing of a lawsuit challenging the constitutionality of a recently enacted New York law that would restrict consumer access to safe and beneficial health products. The suit seeks an injunction to prohibit

Bast rejoins Greater Than One as chief strategy officer

Bast rejoins Greater Than One as chief strategy officer

NEW YORK — Andrew Bast will be rejoining Media marketing and technology agency Greater Than One as chief strategy officer. Bast brings the art and science of strategic planning to forge dynamic, insight-driven strategies which resonate deeply with clients’ customers, the agency says. He has launched and grown many brands, including Nexium, Rexulti, Seroquel, Enbrel,

Valdez is COO of Greater Than One

Valdez is COO of Greater Than One

NEW YORK — Jason Valdez has been promoted to chief operating officer of Greater Than One, a media marketing and technology agency focused on healthcare. He is responsible for overall operations and ensuring the agency’s mission of building better healthcare experiences for customers. He will work directly with CEO Elizabeth Apelles to align the agency

Loblaw to invest over $2 billion to open more than 40 additional stores

Loblaw to invest over $2 billion to open more than 40 additional stores

BRAMPTON, ON – Loblaw Cos., Canada’s food and pharmacy retail leader, expects to invest more than $2 billion dollars into the Canadian economy in 2024. This record investment reflects Loblaw’s commitment to enhancing its store network, creating job opportunities, and improving accessibility to affordable food and healthcare services for communities across the country. The Company’s capital investments this

1 2 3 1,430
PP_1170x120_10-25-21